Pediatrix Medical (MD) Cash & Current Investments (2009 - 2026)

Pediatrix Medical (MD) has 18 years of Cash & Current Investments data on file, last reported at $329.0 million in Q1 2026.

• Quarterly Cash & Current Investments rose 50.1% year-over-year to $329.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $329.0 million (up 50.1% YoY) and the FY2025 annual result came in at $499.7 million, up 43.39% from the prior year.
• Cash & Current Investments declined to $329.0 million in Q1 2026 per MD's latest filing, from $499.7 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $499.7 million in Q4 2025 and bottomed at $96.8 million in Q1 2022.
• The 5-year median for Cash & Current Investments is $133.2 million (2024), against an average of $211.4 million.
• The widest annual swing landed in 2022, when Cash & Current Investments tumbled 78.84%; it then surged 161.51% in 2025.
• Tracing MD's Cash & Current Investments over 5 years: stood at $103.1 million in 2022, then soared by 72.46% to $177.7 million in 2023, then soared by 96.07% to $348.5 million in 2024, then soared by 43.39% to $499.7 million in 2025, then tumbled by 34.17% to $329.0 million in 2026.
• Per Business Quant, the three latest MD Cash & Current Investments figures stand at $329.0 million (Q1 2026), $499.7 million (Q4 2025), and $463.1 million (Q3 2025).

Peer Comparison